Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 6172626, 7 pages
https://doi.org/10.1155/2017/6172626
Research Article

Synthesis, Spectroscopic, and Thermal Investigations of Metal Complexes with Mefenamic Acid

Institute of General and Ecological Chemistry, Faculty of Chemistry, Lodz University of Technology, 116 Zeromskiego Street, 90-924 Lodz, Poland

Correspondence should be addressed to Karolina Kafarska; lp.zdol.p@aksrafak.anilorak

Received 18 September 2017; Revised 16 November 2017; Accepted 21 November 2017; Published 18 December 2017

Academic Editor: Maria F. Carvalho

Copyright © 2017 Karolina Kafarska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. Vane and R. M. Botting, “Mechanism of action of nonsteroidal anti-inflammatory drugs,” American Journal of Medicine, vol. 104, no. 3 A, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Vane, “Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs,” Nature: New biology, vol. 231, no. 25, pp. 232–235, 1971. View at Publisher · View at Google Scholar · View at Scopus
  3. F. A. Aly, S. A. Al-Tamimi, and A. A. Alwarthan, “Determination of flufenamic acid and mefenamic acid in pharmaceutical preparations and biological fluids using flow injection analysis with tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection,” Analytica Chimica Acta, vol. 416, no. 1, pp. 87–96, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. N. Cimolai, “The potential and promise of mefenamic acid,” Expert Review of Clinical Pharmacology, vol. 6, no. 3, pp. 289–305, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Cesur and S. Gokbel, “Crystallization of mefenamic acid and polymorphs,” Crystal Research and Technology, vol. 43, no. 7, pp. 720–728, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. I. H. Sahin, M. M. Hassan, and C. R. Garrett, “Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science,” Cancer Letters, vol. 345, no. 2, pp. 249–257, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Ghanghas, S. Jain, C. Rana, and S. N. Sanyal, “Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer,” Biomedicine & Pharmacotherapy, vol. 78, pp. 239–247, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Jasya and K. Hideo, Jpn. Patent No. 59-175220, 1986.
  9. K. Hirojuki, J. Mitihiro, and S. Enuhisa, Jpn. Patent No. 69-134541, 1989.
  10. F. Dimiza, S. Fountoulaki, A. N. Papadopoulos et al., “Non-steroidal antiinflammatory drug-copper(II) complexes: Structure and biological perspectives,” Dalton Transactions, vol. 40, no. 34, pp. 8555–8568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. S. B. Etcheverry, D. A. Barrio, A. M. Cortizo, and P. A. M. Williams, “Three new vanadyl(IV) complexes with non-steroidal anti-inflammatory drugs (Ibuprofen, Naproxen and Tolmetin). Bioactivity on osteoblast-like cells in culture,” Journal of Inorganic Biochemistry, vol. 88, no. 1, pp. 94–100, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Núñez, A. Fernández-Lodeiro, J. Fernández-Lodeiro, J. Carballo, J. L. Capelo, and C. Lodeiro, “Synthesis, spectroscopic studies and in vitro antibacterial activity of Ibuprofen and its derived metal complexes,” Inorganic Chemistry Communications, vol. 45, pp. 61–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Feng, X. Du, H. Liu et al., “Manganese-mefenamic acid complexes exhibit high lipoxygenase inhibitory activity,” Dalton Transactions, vol. 43, no. 28, pp. 10930–10939, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Totta, A. A. Papadopoulou, A. G. Hatzidimitriou, A. Papadopoulos, and G. Psomas, “Synthesis, structure and biological activity of nickel(II) complexes with mefenamato and nitrogen-donor ligands,” Journal of Inorganic Biochemistry, vol. 145, pp. 79–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ashraf, W. A. Siddiqui, J. Akbar et al., “Metal complexes of benzimidazole derived sulfonamide: Synthesis, molecular structures and antimicrobial activity,” Inorganica Chimica Acta, vol. 443, pp. 179–185, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Ramzan, S. Saleem, B. Mirza, S. Ali, F. Ahmed, and S. Shahzadi, “Synthesis, characterization, and biological activity of transition metals complexes with mefenamic acid (NSAIDs),” Russian Journal of General Chemistry, vol. 85, no. 7, pp. 1745–1751, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. C. T. Dillon, T. W. Hambley, B. J. Kennedy et al., “Gastrointestinal toxicity, antiinflammatory activity, and superoxide dismutase activity of copper and zinc complexes of the antiinfiammatory drug indomethacin,” Chemical Research in Toxicology, vol. 16, no. 1, pp. 28–37, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Kafarska, D. Czakis-Sulikowska, and W. M. Wolf, “Novel Co(II) and Cd(II) complexes with non-steroidal anti-inflammatory drugs: Synthesis, properties and thermal investigation,” Journal of Thermal Analysis and Calorimetry, vol. 96, no. 2, pp. 617–621, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. P. Sharma, S. Singh, A. Singh, and V. Ferretti, “Spectra-structure relationship: Synthesis, characterization of copper(II) complexes with ibuprofenate, o-methoxybenzoate, p-ethoxybenzoate and single crystal X-ray structure determination of [trans-Cu(en)2(H2O)2](L)2 where en = ethylenediammine, L = o-methoxybenzoate/p-ethoxybenzoate,” Journal of Molecular Structure, vol. 918, no. 1-3, pp. 188–193, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. C. Dendrinou-Samara, D. P. Kessissoglou, G. E. Manoussakis, D. Mentzafos, and A. Terzis, “Copper(II) complexes with anti-inflammatory drugs as ligands. Molecular and crystal structures of bis(dimethyl sulphoxide)tetrakis(6-methoxy-α-methyl-2-naphthaleneacetato)dicopper(II) and bis(dimethyl sulphoxide)tetrakis[1-methyl-5-(p-toluoyl)-1H-pyrrole-2-acetato]dicopper(II),” Journal of the Chemical Society, Dalton Transactions, no. 3, pp. 959–965, 1990. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Brzyska and W. Ożga, “Preparation and properties of rare earth element complexes with mephenamic acid,” Polish Journal of Chemistry, vol. 67, p. 619, 1993. View at Google Scholar
  22. A. Topacli and S. Ide, “Molecular structures of metal complexes with mefenamic acid,” Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 5, pp. 975–982, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Kovala-Demertzi, V. Dokorou, Z. Ciunik, N. Kourkoumelis, and M. A. Demertzis, “Organotin mefenamic complexes-preparations, spectroscopic studies and crystal structure of a triphenyltin ester of mefenamic acid: Novel anti-tuberculosis agents,” Applied Organometallic Chemistry, vol. 16, no. 7, pp. 360–368, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Czakis-Sulikowska, A. Malinowska, and K. Kafarska, “Complexes of Mn(II), Cu(II) and Cd(II) with bipyridine isomers and lactates,” Polish Journal of Chemistry, vol. 80, no. 12, pp. 1945–1958, 2006. View at Google Scholar · View at Scopus
  25. W. J. Geary, “The use of conductivity measurements in organic solvents for the characterisation of coordination compounds,” Coordination Chemistry Reviews, vol. 7, no. 1, pp. 81–122, 1971. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, John Wiley & Sons, Inc., New York, NY, USA, 2009.